Maryam Lustberg: In honor of PCDI’s founder Anne Loeser this piece stands as a heartfelt tribute to her legacy following her passing on October 10, 2023 from metastatic breast cancer

Maryam Lustberg recently shared a post on LinkedIn:

“In honor of PCDI’s founder Anne Loeser, whose visionary leadership and unwavering dedication propelled this work forward since the inception of PCDI in 2019, this piece stands as a heartfelt tribute to her legacy following her passing on October 10, 2023 from metastatic breast cancer.

Honored to work with Anne Loeser and the entire patient advocate team and scientific advisory on this initiative which has changed how we think about dosing in advanced cancer.”

Read further.
Source: Maryam Lustberg/LinkedIn

Dr. Maryam Lustberg is the Director of the Center for Breast Cancer at Smilow Cancer Hospital and Yale Cancer Center, and Chief of Breast Medical Oncology at Yale Cancer Center. She is also an Associate Professor of Medicine (Medical Oncology). She has been recognized for her patient-focused care with awards that include being rated by Forbes as one of the top breast medical oncologists in the nation and named to the Castle Connolly list of “Regional Top Doctors,” and “Exceptional Women in Medicine” for 2020. Dr. Lustberg is a member of the ASCO Annual Meeting Education Committee, Patient and Survivor Care Education Committee, and Neuropathy Expert Guideline Panel. She is the President and on the Board of Directors for the international organization Multinational Association of Supportive Care in Cancer (MASCC). She serves as an Associate Editor for the Journal of Cancer Survivorship.